Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001088094 | SCV000287517 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568055 | SCV000671058 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000226380 | SCV000716300 | likely benign | not provided | 2020-01-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000226380 | SCV001152024 | likely benign | not provided | 2018-07-01 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000226380 | SCV004219060 | benign | not provided | 2023-01-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003919950 | SCV004732783 | likely benign | POLD1-related condition | 2023-02-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |